Cite

HARVARD Citation

    Tanei, T. et al. (2016). Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells. Breast cancer research. 18 (1), pp. 1-9. [Online]. 
  
Back to record